PD98059 and limettin ameliorated neuroinflammation and restored cell viability associated with improved histopathological and behavioral alterations as well as restoring AD hallmarks namely, Aβ and p-tau observed in SAD-induced in mice. The gene discussed is MAPT; the disease is Alzheimer disease.